Jump Financial, LLC Heron Therapeutics, Inc. Transaction History

Jump Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.71 - $3.06 $27,360 - $48,960	16,000 New	16,000 $44,000
Q4 2022 Feb 13, 2023	BUY	$2.25 - $4.67 $30,048 - $62,367	13,355 Added 19.96%	80,266 $200,000
Q3 2022 Nov 07, 2022	BUY	$2.66 - $5.37 $177,983 - $359,312	66,911 New	66,911 $282,000
Q2 2022 Aug 09, 2022	SELL	$2.3 - $6.29 $67,070 - $183,422	-29,161 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$4.63 - $9.94 $135,015 - $289,860	29,161 New	29,161 $167,000
Q4 2021 Feb 10, 2022	SELL	$8.35 - $12.6 $587,222 - $886,107	-70,326 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$10.13 - $15.0 $712,402 - $1.05 Million	70,326 New	70,326 $752,000
Q2 2021 Aug 13, 2021	SELL	$13.27 - $18.48 $625,017 - $870,408	-47,100 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$14.49 - $20.72 $682,479 - $975,912	47,100 New	47,100 $763,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.